Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (126)

1

First-line maintenance therapy of adult patients with BCG-naïve high-risk non-muscle-invasive bladder cancer - A Phase 3, Open-Label, Multi-Center, Randomized Study Evaluating the Efficacy and Safety of TAR-200 in Combination with Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants with BCG-naïve High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) - SunRISe-3 - AB 85/23 of AUO

enthalten in: Aktuelle Urologie | 2023

2

Multimodality treatment in high-risk and very high-risk prostate cancer : outcomes from international phase III randomized controlled trials

enthalten in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al | 2022

von Mathier, E. | Heusel, A. | Shelan, M.

CommentOn: J Clin Oncol. 2021 Mar 1;39(7):787-796. - PMID 33471548

3

enthalten in: Aktuelle Urologie | 2021

von Rexer, H. | De Santis, M. | Doehn, C.

4

Early salvage radiation therapy of the prostate bed appears to be equally effective compared to adjuvant radiation therapy after radical prostatectomy

enthalten in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al | 2020

von Shelan, M. | Aebersold, D. | Ghadjar, P.

5

Positron emission tomography-guided treatment in early-stage favorable Hodgkin lymphoma : final results of the international randomized phase III HD16 trial conducted by the German Hodgkin Study Group

enthalten in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al | 2020

von Nieder, C.

6

Clinical implications of the PORTEC-3 trial for the treatment of high-risk endometrial cancer

enthalten in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al | 2020

von Waltar, T. | Marnitz, S.

7

Adjuvant chemotherapy with Capecitabine as new standard for resected cholangiocarcinomas - a look at the BILCAP trial

enthalten in: Zeitschrift fur Gastroenterologie | 2018

von Liotta, L. | Quante, M.

8

Radiochemotherapy improves failure-free survival in stage III endometrial cancer : Final results of the PORTEC-3 trial

enthalten in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al | 2017

von Krug, D. | Arians, N.

9

enthalten in: Aktuelle Urologie | 2017

von Rexer, H. | Graefen, M. | Grimm, M.

10

Janus kinase inhibitor baricitinib for rheumatoid arthritis : Randomized, double-blind, placebo- and active-controlled, phase 3 study evaluating the efficacy and safety of baricitinib in patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to methotrexate therapy (RA-BEAM)

enthalten in: Der Internist | 2017

von Alten, R. | Nitschmann, S.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]